| abstract |
The invention relates to pharmaceutical compositions for the prophylaxis or treatment of CNS disorders, such as Parkinson's disease, restless legs syndrome, Parkinson's syndrome plus, depression, fibromyalgia and / or parkinsonism symptoms containing rotigotine dihydrogen phosphate, wherein the pH of the composition is ≤5. The compositions can be used as part of a transdermal delivery system, for example, in an ionophoretic system. The use of these compositions is characterized by improved transdermal drug delivery to the patient. |